Radient Pharmaceuticals Corporation fka RXPC

[dcspka]

RXPC Detractors are currently able to rely on lack of public news. Until then all uncovered information is compelling but by nature not conclusive until the smoking gun appears. The Takeover debate can not be settled until key pieces of news are actually announced.

The next real news should appear soon regarding the Rosen lawsuit. If the terms of the suit are executed without continued delay and Rosen is paid off to go away, it will be clear that RXPC has definite plans going forward. They would not agree to pay out 2.5 million dollars to shysters if the company did not have valuable properties with a clear plan of putting them to good use.

The Creeping Takeover is being executed thru lender debt conversion to shares and then sold in a clandestine manner to a group of select investors. Its silly to assume the massive trades we have seen are Retail flippers. Any objective investor who has followed the trading volumes and corresponding bid/ask prices knows this.

Select RXPC detractors have created disinformation non-stop 7 days a week to put the company in the worst light possible. Pay attention to the methodology- the best way to tell a lie is to sandwich it between two lesser truths. The bottom line purpose is to dissuade Retail Investors from owning shares.

When the Takeover is announced, the New Owners will most likely swap Provista shares for your RXPC stock. Resist closing your position out- hold your new shares until the IPO actually occurs- it is then you will see the true value of the company, and what their plans are going forward.